8,677 CME Group Inc. $CME Shares Sold by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund lessened its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 32.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,965 shares of the financial services provider’s stock after selling 8,677 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in CME Group were worth $4,706,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. BlackRock Inc. acquired a new stake in shares of CME Group during the 2nd quarter valued at $6,749,965,000. Bank of America Corp DE raised its holdings in shares of CME Group by 39.1% during the first quarter. Bank of America Corp DE now owns 4,019,944 shares of the financial services provider’s stock worth $1,187,290,000 after acquiring an additional 1,130,587 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in CME Group during the second quarter valued at $867,313,000. Alphabet Inc. purchased a new position in CME Group in the second quarter valued at about $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in CME Group in the second quarter valued at about $629,771,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CME. Piper Sandler restated an “overweight” rating and set a $330.00 price target (up from $295.00) on shares of CME Group in a research note on Thursday, October 22nd. Deutsche Bank cut shares of CME Group from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $286.00 to $270.00 in a report on Wednesday, August 19th. TD Cowen raised their target price on CME Group from $292.00 to $300.00 and gave the company a “buy” rating in a report on Monday, October 5th. Wall Street Zen raised CME Group from a “sell” rating to a “hold” rating in a research report on Saturday, October 31st. Finally, UBS Group increased their price objective on CME Group from $270.00 to $310.00 and gave the company a “neutral” rating in a report on Thursday, October 22nd. Ten equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $314.44.

Read Our Latest Research Report on CME Group

Insider Activity

In other CME Group news, CEO Terrence Duffy sold 15,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $274.44, for a total value of $4,116,600.00. Following the completion of the sale, the chief executive officer owned 40,630 shares in the company, valued at approximately $11,150,497.20. This trade represents a 26.96% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Julie Winkler sold 10,079 shares of the business’s stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $305.15, for a total value of $3,075,606.85. Following the sale, the insider owned 21,482 shares in the company, valued at approximately $6,555,232.30. This represents a 31.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 33,511 shares of company stock valued at $9,714,580. Corporate insiders own 0.30% of the company’s stock.

CME Group Stock Performance

CME opened at $317.97 on Monday. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16. The firm has a market capitalization of $113.81 billion, a P/E ratio of 26.08, a price-to-earnings-growth ratio of 3.88 and a beta of 0.15. The stock’s 50 day moving average price is $286.01 and its two-hundred day moving average price is $281.54. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, beating analysts’ consensus estimates of $2.99 by $0.03. CME Group had a net margin of 63.33% and a return on equity of 16.23%. The firm had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.71 billion. During the same period in the prior year, the firm earned $2.68 EPS. The business’s revenue was up 10.6% on a year-over-year basis. On average, equities analysts forecast that CME Group Inc. will post 12.35 earnings per share for the current year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 30th. Investors of record on Friday, December 11th will be paid a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.6%. The ex-dividend date is Friday, December 11th. CME Group’s payout ratio is currently 42.66%.

CME Group Company Profile

(Free Report)

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

Featured Stories

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.